Macquarie Group’s NextCure NXTC Stock Holding History

Macquarie Group’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,500	Closed	-$69K	–	1665
2025 Q2	$69K	Hold	12,500	–	–	﹤0.01%	1585
2025 Q1	$72K	Hold	12,500	–	–	﹤0.01%	1561
2024 Q4	$116K	Hold	12,500	–	–	﹤0.01%	1542
2024 Q3	$206K	Hold	12,500	–	–	﹤0.01%	1551
2024 Q2	$239K	Hold	12,500	–	–	﹤0.01%	1538
2024 Q1	$335K	Hold	12,500	–	–	﹤0.01%	1480
2023 Q4	$171K	Hold	12,500	–	–	﹤0.01%	1556
2023 Q3	$194K	Hold	12,500	–	–	﹤0.01%	1529
2023 Q2	$270K	Hold	12,500	–	–	﹤0.01%	1525
2023 Q1	$222K	Hold	12,500	–	–	﹤0.01%	1545
2022 Q4	$212K	Hold	12,500	–	–	﹤0.01%	1598
2022 Q3	$413K	Hold	12,500	–	–	﹤0.01%	1550
2022 Q2	$705K	Hold	12,500	–	–	﹤0.01%	1549
2022 Q1	$729K	Sell	12,500 -20	-0.2%	-$1.25K	﹤0.01%	1601
2021 Q4	$901K	Hold	12,520	–	–	﹤0.01%	1578
2021 Q3	$1.01M	Hold	12,520	–	–	﹤0.01%	1582
2021 Q2	$1.21M	Hold	12,520	–	–	﹤0.01%	1563
2021 Q1	$1.5M	Sell	12,520 -9	-0.1%	-$1.3K	﹤0.01%	1287
2020 Q4	$1.64M	Buy	12,529 +4,166	+50%	+$538K	﹤0.01%	1163
2020 Q3	$883K	Hold	8,363	–	–	﹤0.01%	1263
2020 Q2	$2.15M	Buy	8,363 +30	+0.4%	+$11.4K	﹤0.01%	989
2020 Q1	$3.71M	Hold	8,333	–	–	0.01%	777
2019 Q4	$5.63M	Buy	+8,333	New	+$4.18M	0.01%	782

Other funds holding NXTC

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CPA

Cardiff Park Advisors Carlsbad, California $1.29B AUM 23.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group's NXTC Position: Q3 2025 in Review

Macquarie Group sold out of NextCure (NXTC) in Q3 2025, closing a stake of 12,500 shares — an estimated $69K sold.

Macquarie Group first reported a position in NXTC in Q4 2019 and held it in 23 quarters. The position peaked at $5.63M in Q4 2019. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

Macquarie Group reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
Macquarie Group sold 12,500 NextCure shares in Q3 2025, an estimated $69K.
Macquarie Group first reported a position in NextCure in Q4 2019 and held it in 23 quarters.
Macquarie Group's NextCure position peaked at $5.63M in Q4 2019.
17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Macquarie Group's 13F filing for Q3 2025, filed 13 Nov 2025.